Monashee Investment Management LLC Avrobio, Inc. Transaction History

Monashee Investment Management LLC

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$10.54 - $19.3 $310,771 - $569,060
-29,485 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$12.79 - $17.1 $377,113 - $504,193
29,485 New
29,485 $411,000
Q3 2018

Nov 13, 2018
SELL
$26.95 - $52.7 $2.83 Million - $5.53 Million
-105,000 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$28.08 - $31.2 $2.95 Million - $3.28 Million
105,000 New
105,000 $3 Million

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email